Endovascular thrombectomy (EVT) is effective and safe for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) in major clinical trials. Whether the benefit of EVT in randomized trials could be generalized to clinical practice, especially in developing countries, remains unknown. The prospective Chinese ANGEL-ACT Registry (Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke) was established to evaluate the utilization, and subsequent outcomes of EVT treated AIS patients. This study is a multi-center, prospective registry study initiated by researchers, funded by National Key R\&D Program of China. A total of 2,000 patients with acute ischemic stroke will undergo endovascular treatment. The hypothesis was that favorable outcomes from clinical trials could be achieved in clinical practice in China.
Study Type
OBSERVATIONAL
Enrollment
2,004
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China
Functional independence at 90 days (modified Rankin Scale of 0-2)
The range of modified Rankin Scale was from 0 to 6. 0-No symptoms;1-No significant disability;2-Slight disability;3-Moderate disability;4-Moderately severe disability;5-Severe disability;6 -Dead.A higher score indicates worse a outcome.
Time frame: 90±7 days after enrollment
Symptomatic intracranial hemorrhage (sICH) within 12-36 hours after the procedure
Heidelberg Bleeding Classification): new intracranial hemorrhage detected by brain imaging associated with ≥4 points total National Institutes of Health Stroke Scale (NIHSS), ≥2 points in one NIHSS category, leading to intubation/ hemicraniectomy/ EVD placement or other major medical/surgical intervention, or absence of alternative explanation for deterioration
Time frame: 12-36 hours after the procedure
Time from symptom onset to recanalization
Time frame: The end of the procedure
Recanalization rate at the end of the procedure
mTICI score 2b-3
Time frame: at the end of the procedure
Recanalization rate after the first attempt
mTICI score 2b-3
Time frame: At baseline, during the procedure, after the first attempt of endovascular treatment
Changes in NIHSS score immediately after the procedure
difference between NIHSS score immediately after the procedure and baseline
Time frame: within 2 hours after the procedure
Changes in NIHSS score 24 hours after the procedure
difference between NIHSS score 24 hours after the procedure and baseline
Time frame: 24 hours after the procedure
Changes in NIHSS score 7 days after the procedure or at discharge
difference between NIHSS score 7 days after the procedure or discharge and baseline
Time frame: 7 days after the procedure or discharge
EQ-5D 90 days after the procedure
EQ-5D is a standardized instrument for measuring generic health status. Rated level can be coded as a number 1, 2, or 3, which indicates having no problems for 1, having some problems for 2, and having extreme problems for 3. As a result, a person's health status can be defined by a 5-digit number, ranging from 11111 (having no problems in all dimensions) to 33333 (having extreme problems in all dimensions).A higher score indicates a better outcome.
Time frame: 90±7 days after the procedure
Barthel index (BI) 90 days after the procedure
The BI has a score of 0-100. A higher score indicates a better outcome.
Time frame: 90±7 days after the procedure
Parenchymal hematoma (PH2)
PH2 is defined as hematoma in \>30% of infarct area
Time frame: 12-36 hours after the procedure
Any intracranial hemorrhage on imaging
Time frame: 12-36 hours after the procedure
All-cause mortality within 90 days
Time frame: 90±7 days after the procedure
Time from onset to arrival
Time frame: At baseline, after arrival at the hospital
Time from arrival to imaging
Time frame: At baseline, after taking any brain imaging
Time from imaging to puncture
Time frame: At baseline, during the procedure, after successful groin puncture
Time from puncture to recanalization
Time frame: At baseline, during the procedure, after successful recanalization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.